Samsara Bio Capital, LLC Dice Therapeutics, Inc. Transaction History

Samsara Bio Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $5.28 Million - $6.55 Million	202,773 New	202,773 $5.81 Million
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $1 Million - $2.14 Million	-50,693 Reduced 20.0%	202,773 $6.33 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $329,750 - $552,500	25,000 Added 10.94%	253,466 $3.93 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $3.32 Million - $5.72 Million	228,466 New	228,466 $4.37 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.